These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8292970)

  • 1. Synthesis of prothymosin alpha deduced from nucleotide sequence of the murine cDNA and its effect on the impaired T lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):213-20. PubMed ID: 8292970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase synthesis of biologically active fragment 29-111 of rat prothymosin alpha.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1991 Jun; 13(3):406-11. PubMed ID: 1883531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1988 Dec; 10(6):576-88. PubMed ID: 3266074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2647-52. PubMed ID: 1806285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the central segment of prothymosin-alpha: methodology for handling highly acidic peptides.
    Wilson CL; Monteith WB; Danell AS; Burns CS
    J Pept Sci; 2006 Nov; 12(11):721-5. PubMed ID: 16967434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase syntheses of two deacetyl-thymosin alpha 1 analogues with substitution at position 21 and their effects on low E-rosette-forming lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1992; 3(3-4):159-68. PubMed ID: 1303729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of peptides with potential thymic hormone activity: the synthesis of endo-Arg38a-deacetylthymosin beta 10.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1987 Feb; 9(1):20-30. PubMed ID: 3494463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of an immunologically active fragment analog of prothymosin alpha with enhanced enzymatic stability.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):752-6. PubMed ID: 2070460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2467-71. PubMed ID: 2605693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of [I-NaI3]] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes.
    Abiko T; Nakatsubo S
    Mediators Inflamm; 2000; 9(3-4):201-6. PubMed ID: 11132780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2301-4. PubMed ID: 2279297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the anomalous behaviour on gel-filtration and SDS-electrophoresis of prothymosin-alpha.
    Cordero OJ; Sarandeses CS; Lopez JL; Nogueira M
    Biochem Int; 1992 Dec; 28(6):1117-24. PubMed ID: 1290467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of synthetic thymosin beta 9 fragments on low E-rosette-forming cells of lupus nephritis patients.
    Abiko T; Sekino H
    J Appl Biochem; 1983 Dec; 5(6):446-52. PubMed ID: 6236194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and purification of alpha-neurotoxins from king cobra (Ophiophagus hannah).
    He YY; Lee WH; Zhang Y
    Toxicon; 2004 Sep; 44(3):295-303. PubMed ID: 15302536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus.
    Haritos AA; Goodall GJ; Horecker BL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1008-11. PubMed ID: 6583693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overproduction in Escherichia coli, purification and properties of human prothymosin alpha.
    Evstafieva AG; Chichkova NV; Makarova TN; Vartapetian AB; Vasilenko AV; Abramov VM; Bogdanov AA
    Eur J Biochem; 1995 Aug; 231(3):639-43. PubMed ID: 7649163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis of porcine cholecystokinin-33 in a new resin via FMOC-strategy.
    Penke B; Nyerges L
    Pept Res; 1991; 4(5):289-95. PubMed ID: 1802240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous isolation and determination of prothymosin alpha, parathymosin alpha, thymosin beta 4, and thymosin beta 10.
    Haritos AA; Caldarella J; Horecker BL
    Anal Biochem; 1985 Feb; 144(2):436-40. PubMed ID: 3993908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.